TABLE 2.
Completion | 252 monitored days treatment group (n = 41) | 168 monitored days referent group (n = 36) | Total (N = 77) | ||
---|---|---|---|---|---|
% | n (%) | Range | n (%) | Range | n (%) |
80–100 | 13 (32) | 202–251 | 11 (31) | 135–167 | 24 (31) |
60– < 80 | 10 (24) | 152–201 | 3 (8) | 101–134 | 13 (17) |
40– < 60 | 8 (20) | 101–151 | 9 (25) | 68–100 | 17 (22) |
20– < 40 | 8 (20) | 51–100 | 10 (28) | 34–67 | 18 (23) |
<20 | 2 (5) | 15–50 | 3 (8) | 2–33 | 5 (7) |